Neurocrine Biosciences
NBIX
#1350
Rank
S$18.16 B
Marketcap
$179.45
Share price
4.88%
Change (1 day)
11.91%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Total assets

Total assets on the balance sheet as of September 2024 : S$4.77 Billion

According to Neurocrine Biosciences 's latest financial reports the company's total assets are S$4.77 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Neurocrine Biosciences - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31S$4.29 B35.23%
2022-12-31S$3.17 B13.34%
2021-12-31S$2.80 B22.09%
2020-12-31S$2.29 B30.34%
2019-12-31S$1.76 B29.77%
2018-12-31S$1.35 B24.07%
2017-12-31S$1.09 B106.96%
2016-12-31S$0.52 B-21.32%
2015-12-31S$0.67 B109.14%
2014-12-31S$0.32 B63.87%
2013-12-31S$0.19 B-18.23%
2012-12-31S$0.23 B33.75%
2011-12-31S$0.17 B-3.68%
2010-12-31S$0.18 B87.12%
2009-12-31S$99.42 M-41.17%
2008-12-31S$0.16 B-57.55%
2007-12-31S$0.39 B-33.37%
2006-12-31S$0.59 B-25.72%
2005-12-31S$0.80 B-5.04%
2004-12-31S$0.84 B-10.16%
2003-12-31S$0.94 B103.87%
2002-12-31S$0.46 B-27.87%
2001-12-31S$0.64 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
S$3.82 B-19.93%๐Ÿ‡บ๐Ÿ‡ธ USA
S$24.36 B 410.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$4.61 M-99.90%๐Ÿ‡บ๐Ÿ‡ธ USA
S$102.10 B 2,038.81%๐Ÿ‡บ๐Ÿ‡ธ USA
S$193.69 B 3,957.20%๐Ÿ‡บ๐Ÿ‡ธ USA
S$296.40 B 6,108.66%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.73 B-63.58%๐Ÿ‡บ๐Ÿ‡ธ USA
S$10.03 M-99.79%๐Ÿ‡บ๐Ÿ‡ธ USA